Semaglutide is not a standalone solution for weight loss
In theory, this could counterbalance any insulin resistance from tesamorelin GH elevation
However, direct immune effects are still being studied
You have to go a step further upstream to figure out whats causing the disease on one level
Weeks after the end of the shortage, the OFA blasted the FDAs decision, calling it arbitrary and saying it could deprive patients of a vital treatment for type 2 diabetes and obesity. The OFA sued the FDA, alleging that the move to take tirzepatide off shortage lacked any semblance of lawful process. The complaint noted that Congress allows certain drugs to be compounded when supply is limited, with the goal of helping the industry continue to deliver therapies to patients who need them
References (1) Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH